These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16896493)

  • 1. [Pneumocystis jiroveci pneumonia characteristics in adults with AIDS with or without antiretroviral therapy].
    Bahamondes M L; Villar Z MJ; Orellana C C; González R J; Montenegro U C
    Rev Chilena Infectol; 2006 Sep; 23(3):215-9. PubMed ID: 16896493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jiroveci pneumonia in adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy.
    Patel N; Koziel H
    Treat Respir Med; 2004; 3(6):381-97. PubMed ID: 15658884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular granulomatous Pneumocystis jiroveci pneumonia consequent to delayed immune reconstitution inflammatory syndrome.
    Taeb AM; Sill JM; Derber CJ; Hooper MH
    Int J STD AIDS; 2018 Dec; 29(14):1451-1453. PubMed ID: 30114992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
    Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
    Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii pneumonia.
    Schliep TC; Yarrish RL
    Semin Respir Infect; 1999 Dec; 14(4):333-43. PubMed ID: 10638513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia.
    Lee WS; Hsueh PR; Hsieh TC; Chen FL; Ou TY; Jean SS
    J Microbiol Immunol Infect; 2017 Aug; 50(4):547-548. PubMed ID: 27094385
    [No Abstract]   [Full Text] [Related]  

  • 8. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.
    Qin Y; Lu Y; Zhou Y; Harypursat V; Sun F; Yang S; Tang S; Li Y; He X; Zeng Y; Chen Y
    Trials; 2020 Jun; 21(1):551. PubMed ID: 32571429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
    D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
    AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease.
    Kastenbauer U; Wolf E; Kollan C; Hamouda O; Bogner JR;
    Eur J Med Res; 2009 Jun; 14(6):244-9. PubMed ID: 19541584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia.
    Wislez M; Bergot E; Antoine M; Parrot A; Carette MF; Mayaud C; Cadranel J
    Am J Respir Crit Care Med; 2001 Sep; 164(5):847-51. PubMed ID: 11549544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia.
    Morris A; Wachter RM; Luce J; Turner J; Huang L
    AIDS; 2003 Jan; 17(1):73-80. PubMed ID: 12478071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy.
    Ball SC
    AIDS Read; 2007 Dec; 17(12):583-6, 593. PubMed ID: 18178976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.
    Abgrall S; Matheron S; Le Moing V; Dupont C; Costagliola D;
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):151-8. PubMed ID: 11242182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Schneider MM; Borleffs JC; Stolk RP; Jaspers CA; Hoepelman AI
    Lancet; 1999 Jan; 353(9148):201-3. PubMed ID: 9923876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early development of immune reconstitution inflammatory syndrome related to Pneumocystis pneumonia after antiretroviral therapy.
    Mok HP; Hart E; Venkatesan P
    Int J STD AIDS; 2014 Apr; 25(5):373-7. PubMed ID: 24122663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
    Goldie SJ; Kaplan JE; Losina E; Weinstein MC; Paltiel AD; Seage GR; Craven DE; Kimmel AD; Zhang H; Cohen CJ; Freedberg KA
    Arch Intern Med; 2002 Apr; 162(8):921-8. PubMed ID: 11966344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy.
    Crothers K; Huang L
    HIV Med; 2003 Oct; 4(4):346-9. PubMed ID: 14525547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.